OMS906
Omeros
['concept study', 'obinu']
the masp-3 inhibitor oms906 led to clinical efficacy in a proof-of-concept study for patients with paroxysmal nocturnal hemoglobinuria. #eha2023 | 
Oncology news and insights from leading researchers and cancer centers.